LIVZON
LIVE

Serial Number

87543606

Owner

Livzon Pharmaceutical Group Inc.

Attorney

Nicholas D. Wells

Filing Date

Jul 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

LIVZON Trademark

Serial Number: 87543606 • Registration: 5517141

LIVZON is a trademark filed by Livzon Pharmaceutical Group Inc. on July 26, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Livzon Pharmaceutical Group Inc. (3 trademarks)

The headquarters building,No.38 Chuangye
Guangdong Province 519090 , CN

Entity Type: 99

Trademark Details

Filing Date

July 26, 2017

Registration Date

July 17, 2018

Published for Opposition

May 1, 2018

Goods & Services

Medicines for the treatment of gastrointestinal diseases, for human purposes; [ Pharmaceutical products for the prevention and treatment of cancer, for human purposes; Tumor suppressing agents, for human purpose; ] Antibacterial pharmaceuticals; [ Cardiovascular pharmaceuticals; ] Pharmaceuticals, namely, anti-infectives; [ Medical preparations for slimming purposes; Food for babies; Bulk drugs, namely, drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Bulk drug in the nature of a pharmaceutical preparation for the treatment of cardiovascular disease, hypertension, alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, Infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; Chinese medicine nostrum in the nature of natural remedy preparations for the treatment of cardiovascular disease, hypertension, alzheimer disease, depression, cancer, diabetes, lung disease, liver disease, cerebral ischemia, prostate disease, Infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; Chinese medicine nostrum in the nature of natural remedy preparations for the treatment of cancer; Antibiotics; Biochemical medicines for the treatment of pneumonia, urinary tract infection, gynecological infections, skin and skin structure infections, meningitis, septicemia, cancer, diabetes, prostate disease, Infertility, rheumatoid arthritis, immune system disease, and gastrointestinal disease; ] Biochemical drugs for treatment of gastrointestinal diseases [ ; Blood products, namely, immunoglobulins for medical or clinical use; Blood products for medical purposes, namely, blood plasma, reagent blood cells; Blood products for medical purposes, namely, blood plasma products, red blood cell products, and leukocyte products; Dietetic foods adapted for medical use; Dietetic beverages adapted for medical purposes ]

[ Medical apparatus for detecting cancer; Medical device for treating cancer; Medical apparatus and instruments for use in surgery; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Ultrasound diagnostic apparatus; X-ray diagnostic apparatus; Dental instruments, namely, oral irrigators; Drills for dental applications; Orthodontic machines and instruments, for dental purposes; Weight lifting machines for physical therapy; Foam rollers for use in physical therapy; Manually-operated exercise equipment for physical therapy purposes; Hearing aids; Baby bottles; Contraceptive apparatus, non-chemical; Artificial limbs; Orthopaedic belts; Orthopaedic knee bandages; Orthopaedic hip prostheses; Sanitary masks for medical purposes; Gloves for medical purposes ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Mar 5, 2025 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Mar 5, 2025 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 5, 2025 APRE
TEAS SECTION 8 RECEIVED
Jul 3, 2024 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 17, 2023 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 21, 2019 TCCA
REGISTERED-PRINCIPAL REGISTER
Jul 17, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 1, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 1, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 11, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 9, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 9, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 9, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 9, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 3, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 3, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 3, 2017 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 1, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2017 NWOS
NEW APPLICATION ENTERED
Jul 29, 2017 NWAP